Cannabinoid system and cyclooxygenases inhibitors
Rationale. The cannabinoid system consists of a complex array of receptors, substances with agonist/antagonist properties for those receptors, biosynthetic machineries and mechanisms for cellular uptake and degradation for endocannabinoids. This system is in interrelation with other systems that com...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Carol Davila University Press
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056416/ |
id |
pubmed-3056416 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-30564162011-04-20 Cannabinoid system and cyclooxygenases inhibitors Păunescu, H Coman, OA Coman, L Ghiţă, I Georgescu, SR Drăia, F Fulga, I Review Rationale. The cannabinoid system consists of a complex array of receptors, substances with agonist/antagonist properties for those receptors, biosynthetic machineries and mechanisms for cellular uptake and degradation for endocannabinoids. This system is in interrelation with other systems that comprise lipid mediators like prostaglandins/leukotrienes systems. A clear antagonist, additive or synergic effect of nonsteroidal anti–inflammatory drugs (NSAIDs)–cannabinoid associations was not yet demonstrated. Aim. The present study tried to summarize the existent data on NSAIDS-cannabinoid system interactions. Carol Davila University Press 2011-02-15 2011-02-25 /pmc/articles/PMC3056416/ /pubmed/21505570 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Păunescu, H Coman, OA Coman, L Ghiţă, I Georgescu, SR Drăia, F Fulga, I |
spellingShingle |
Păunescu, H Coman, OA Coman, L Ghiţă, I Georgescu, SR Drăia, F Fulga, I Cannabinoid system and cyclooxygenases inhibitors |
author_facet |
Păunescu, H Coman, OA Coman, L Ghiţă, I Georgescu, SR Drăia, F Fulga, I |
author_sort |
Păunescu, H |
title |
Cannabinoid system and cyclooxygenases inhibitors
|
title_short |
Cannabinoid system and cyclooxygenases inhibitors
|
title_full |
Cannabinoid system and cyclooxygenases inhibitors
|
title_fullStr |
Cannabinoid system and cyclooxygenases inhibitors
|
title_full_unstemmed |
Cannabinoid system and cyclooxygenases inhibitors
|
title_sort |
cannabinoid system and cyclooxygenases inhibitors |
description |
Rationale. The cannabinoid system consists of a complex array of receptors, substances with agonist/antagonist properties for those receptors, biosynthetic machineries and mechanisms for cellular uptake and degradation for endocannabinoids. This system is in interrelation with other systems that comprise lipid mediators like prostaglandins/leukotrienes systems. A clear antagonist, additive or synergic effect of nonsteroidal anti–inflammatory drugs (NSAIDs)–cannabinoid associations was not yet demonstrated. Aim. The present study tried to summarize the existent data on NSAIDS-cannabinoid system interactions. |
publisher |
Carol Davila University Press |
publishDate |
2011 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056416/ |
_version_ |
1611445358831861760 |